Clinicn Investigator, Assc Prf Surgery, Mass General Research Institute

Associate Professor of Surgery Harvard Medical School

Visiting Surgeon Surgical Oncology, Massachusetts General Hospital

MD University of Michigan Medical School 2001

MPH Harvard School of Public Health 2012

adenoma; adrenal disease; biopsy fine-needle; calcitonin; carcinoma; carcinoma papillary; four-dimensional computed tomography; gene expression profiling; hyperaldosteronism; hyperparathyroidism primary; hyperthyroidism; proto-oncogene proteins b-raf; technetium tc 99m sestamibi; thyroid cancer; thyroid neoplasms; thyroid nodule; thyroidectomy

In addition to her clinical practice which focuses on both benign and malignant thyroid, parathyroid, and adrenal disease, Dr. Lubitz has clinical and translational research interests including prediction and decision-analytic modeling to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders.

Her current projects involve identifying appropriate and effective diagnostic, surgical, and surveillance strategies for patients with primary hyperaldosteronism and thyroid cancer. She obtained a Master of Public Health through the Harvard School of Public Health and completed her fellowship in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training in 2013. She continues as a senior scientist at the MGH Institute for Technology Assessment.